- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06890962
Citicoline Dose on Energy Drink Efficacy
The Effect of Citicoline and Caffeine Dose in a Commercial Energy Drink on Cognitive Performance, Energy Expenditure and Fat Oxidation in Young Adults
The purpose of this study is to determine how the doses of cognitive-enhancing ingredients such as citicoline and caffeine effect the efficacy of acute energy drink consumption for improving cognitive performance (primary outcome), gaming performance, mood, energy expenditure, and fat oxidation. This study will utilize an In vivo acute response, randomized, double-blind, placebo controlled, cross-over trial study design. Participants will complete consent, complete screening, and then undergo familiarization and complete four experimental study visits. In brief, participants will consume a commercially available energy drink specifically formulated to improve cognitive performance with the standard dose of Cognizin, a reduced dose of Cognizin, a reduced dose of caffeine and Cognizin, or a placebo (water, which will be carbonated, matched for flavor, mouthfeel, etc.), then complete a battery of computer-based cognitive performance test, tasks in a video game (Tetris) to assess video game performance, have their resting metabolism analyzed, and then assessments of mood. Following a 1-week washout period, participants will return and consume one of the four remaining beverages and complete the same tasks. They will participate in four experimental visits, each time consuming a different beverage until they have consumed all beverages and completed all necessary tasks.
Question(s) and Hypotheses (stated in null) Q: Does acute consumption of a new formulations (reduced active ingredients [citicoline and caffeine]) of a commercially available energy drink elicit similar improvements in cognitive performance, mood, energy expenditure and fat oxidation in young adults than the standard, currently marketed dose to formulation?
H1: Acute consumption of the commercially available energy drink with standard dosing will improve cognitive performance compared to the reduced dose beverages and the placebo.
H2: Acute consumption of the commercially available energy drink with standard dosing will improve gaming (Tetris) performance compared to the reduced dose beverages and the placebo.
H3: Acute consumption of the commercially available energy drink with standard dosing will improve mood compared to the reduced dose beverages and the placebo.
H4: Acute consumption of a commercially available energy drink with standard dosing will increase energy expenditure and fat oxidation compared to the reduced dose beverages and the placebo.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Fitness: Healthy, recreationally trained (>2 d/wk physical activity)
- BMI: (<30kg/m2) or BF <25% (M) and <32% (F)
Exclusion Criteria:
- <1 hr/wk playing video games
- >=21 servings of >=170.5 mL (or >=6 fl oz) caffeine beverages per week [(PMID: 33525438)]
- Injury or illness
- Habitual nicotine or cannabis use
- Use of prescription ADD/ADHD, anti-depressant, or other central acting medication, or previously diagnosed ADD/ADHD, clinical depression, or other mental health condition
- Use of prescription, OTC, or dietary supplements to support sleep, or having been diagnosed with a clinical sleep condition
- Current or prior chronic (>6 mo) illicit drug or alcohol abuse
- Clinically diagnosed with, or taking medication for a cardiometabolic disease or disorder (e.g., Pre-diabetes, Type II diabetes, high blood pressure, chronic kidney disease, cardiovascular disease, obesity, etc.)
- Clinically diagnosed digestive disorder or sensitivity, or regular use of OTC or dietary supplements to support gastrointestinal pain or discomfort
- Competitive athlete
- Failure to comply with the controls and conditions of this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard Energy Drink
C4 Smart Energy, 1 can, administered acutely
|
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.
|
|
Experimental: Reduced Citicoline Energy Drink
C4 Smart Energy Reduced Citicoline, 1 can, administered acutely
|
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.
|
|
Experimental: Reduced Citicoline and Caffeine Energy Drink
C4 Smart Energy Reduced Citicoline and Caffeine, 1 can, administered acutely
|
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.
|
|
Placebo Comparator: Placebo
Placebo Drink devoid of active ingredients, 1 can, administered acutely
|
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Executive Function
Time Frame: 60 minutes post-drink consumption
|
How well a subject recognizes rules, categories, and manages or navigates rapid decision making.
Assessed as Shifting Attention Task (SAT) Correct Responses - SAT Errors.
|
60 minutes post-drink consumption
|
|
Resting Fat Oxidation
Time Frame: 50 minutes post-drink consumption
|
Resting fat oxidation (g/min) will be quantified from resting, fasted analyses of pulmonary gas exchange.
|
50 minutes post-drink consumption
|
|
Video Game Performance
Time Frame: 90 minutes post-drink consumption
|
Performance in the two-dimensional visuospatial game Tetris.
Participants will be given four minutes of play time on Marathon mode and instructed to maximize the score (points) displayed on the screen.
The total score at the end of play time will be recorded.
|
90 minutes post-drink consumption
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sustained Attention
Time Frame: 60 minutes post-drink consumption
|
Measure of how well a subject can direct and focus cognitive activity on specific stimuli. Assessed using the 4-part Continuous Performance Test, which requires the subject to respond to the target stimulus "B" but not to any other letter. Stimuli are presented at random and the subject responds by pressing the SPACE BAR. Sustained Attention is then quantified as: (Part 2 Correct Responses + Part 3 Correct Responses + Part 4 Correct Responses) - (Part 2 Incorrect Responses + Part 3 Incorrect Responses + Part 4 Incorrect Responses) |
60 minutes post-drink consumption
|
|
Psychomotor Speed
Time Frame: 60 minutes post-drink consumption
|
Measure of how well a subject perceives, attends, responds to visual-perceptual information, and performs motor speed and fine motor coordination. To assess psychomotor speed, participants will complete two tests:
Psychomotor Speed is then quantified as a singular outcome using data aggregated from these two tests as: FTT Right Taps Average + FTT Left Taps Average + SDC Correct Responses |
60 minutes post-drink consumption
|
|
Working Memory
Time Frame: 60 minutes post-drink consumption
|
Measure of how well a subject can perceive and attend to symbols using short-term memory processes. Working memory is assessed via completion of the 4-part Continuous Performance Test, which requires the subject to respond to the target stimulus "B" but not to any other letter. Stimuli are presented at random and the subject responds by pressing the SPACE BAR. Working memory is assessed as: Part 4 Correct Responses - Part 4 Incorrect Responses |
60 minutes post-drink consumption
|
|
Cognitive Flexibility
Time Frame: 60 minutes post-drink consumption
|
Measure of how well subject is able to adapt to rapidly changing and increasingly complex set of directions and/or to manipulate the information. Two tests will be used to assess:
Cognitive Flexibility is then quantified as a singular outcome using data aggregated from these two tests as: SAT Correct Responses - SAT Errors - Stroop Commission Errors |
60 minutes post-drink consumption
|
|
Resting Metabolic Rate
Time Frame: 50 minutes post-drink consumption
|
Resting metabolic rate (kcal/min) will be quantified from resting, fasted analyses of pulmonary gas exchange.
|
50 minutes post-drink consumption
|
|
Resting Respiratory Exchange Ratio
Time Frame: 50 minutes post-drink consumption
|
Resting respiratory exchange ratio will be quantified from resting, fasted analyses of pulmonary gas exchange.
|
50 minutes post-drink consumption
|
|
Total Mood Disturbance
Time Frame: 105-minutes post-drink consumption
|
Total mood disturbance will be quantified using the Profile of Mood State Short Form Questionnaire.
|
105-minutes post-drink consumption
|
|
Vigor-Activity
Time Frame: 105-minutes post-drink consumption
|
Vigor will be quantified using the Profile of Mood State Short Form
|
105-minutes post-drink consumption
|
|
Heart rate
Time Frame: pre-drink consumption, 40-minutes post-drink consumption, 110 minutes post-drink consumption
|
Heart rate will be quantified from a standard 3-lead ECG
|
pre-drink consumption, 40-minutes post-drink consumption, 110 minutes post-drink consumption
|
|
Blood Pressure
Time Frame: pre-drink consumption, 40 minutes post-drink consumption, 110 minutes post-drink consumption
|
Systolic, diastolic, and pulse pressures (mmHg) will be quantified from brachial
|
pre-drink consumption, 40 minutes post-drink consumption, 110 minutes post-drink consumption
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tension
Time Frame: 105 minutes post-drink consumption
|
Tension will be quantified using the Profile of Mood State Short Form Questionnaire.
|
105 minutes post-drink consumption
|
|
Fatigue
Time Frame: 105 minutes post-drink consumption
|
Fatigue will be quantified using the Profile of Mood State Short Form Questionnaire.
|
105 minutes post-drink consumption
|
|
Anger
Time Frame: 105 minutes post-drink consumption
|
Anger will be quantified using the Profile of Mood State Short Form Questionnaire.
|
105 minutes post-drink consumption
|
|
Confusion
Time Frame: 105 minutes post-drink consumption
|
Confusion will be quantified using the Profile of Mood State Short Form Questionnaire.
|
105 minutes post-drink consumption
|
|
Friendliness
Time Frame: 105 minutes post-drink consumption
|
Friendliness will be quantified using the Profile of Mood State Short Form Questionnaire.
|
105 minutes post-drink consumption
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 202302574
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
GE HealthcareCompleted
-
Taiwan Biophotonic CorporationCompletedBlood Pressure | Blood Pressure VariabilityTaiwan
-
Université de SherbrookeRecruitingBlood Pressure | Blood Pressure Monitoring, Ambulatory | Blood Pressure, High | Blood Pressure ManagementCanada
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
Centre Hospitalier Universitaire VaudoisRecruitingBlood Pressure | Blood Pressure DisordersSwitzerland
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
Istituto Auxologico ItalianoCompletedArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
Clinical Trials on Energy drink consumption
-
Nathaniel JenkinsCompletedMood | Caffeine | Exercise Performance | Energy Drink | Cardiovascular SafetyUnited States
-
University of ZurichUniversity of Lausanne; SNF Swiss National FoundationCompleted
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
University of the PacificCompletedBlood Pressure | Electrical Alternation of HeartUnited States
-
ETH ZurichRecruitingNutrition, Healthy | Leucine SensitivitySwitzerland
-
Université de MontréalUnknown
-
Karolinska InstitutetRegion Stockholm; Research department, Ersta HospitalTerminated
-
David Grant U.S. Air Force Medical CenterCompletedQTc IntervalUnited States